CHARLES H HOOD FOUNDATION: Form 990PF, tax year 2023
View the entire original 990 at ProPublica ↗
- Organization
- CHARLES H HOOD FOUNDATION (EIN 04-3507847)
- Tax period
- 2023-01-01 to 2023-12-31
- Filed
- 2024-11-07
- IRS object ID
- 202403129349100420
- Schema version
- 2023v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990-PF
- Schedule B
- Accounting Fees Schedule
- All Oth Prog Rltd Investments Sch
- Expenditure Responsibility Stmt
- Investments Corp Bonds Schedule
- Investments Corp Stock Schedule
- Investments Other Schedule2
- Legal Fees Schedule
- Other Assets Schedule
- Other Decreases Schedule
- Other Expenses Schedule
- Other Income Schedule2
- Other Increases Schedule
- Other Professional Fees Schedule
- Taxes Schedule
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-11-07T08:31:31-06:00 | ReturnTs |
| Tax Period End | 2023-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 042571780 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AAFCPAS INC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 50 WASHINGTON STREET | AddressLine1Txt |
| City | WESTBOROUGH | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 01581 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990PF | ReturnTypeCd |
| Tax Period Begin | 2023-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 043507847 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CHARLES H HOOD FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | CHAR | BusinessNameControlTxt |
| Phone | 6172792230 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2 BOYLSTON STREET 4TH FLOOR | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02116 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | NEIL SMILEY | PersonNm |
| Person Title | PRESIDENT AND TREASURER | PersonTitleTxt |
| Phone | 6172792230 | PhoneNum |
| Signature | 2024-11-06 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | JOYCE RIPIANZI CPA | PreparerPersonNm |
| PTIN | P00548581 | PTIN |
| Phone | 5083669100 | PhoneNum |
| Preparation | 2024-11-06 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2023 | TaxYr |
| Build TS | 2024-10-15 13:58:12Z | BuildTS |
Form 990-PF IRS990PF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization501c3 Exempt PF | Yes (X) | Organization501c3ExemptPFInd |
| FMV Assets EOY | $72,008,150 | FMVAssetsEOYAmt |
| Method Of Accounting Cash | Yes (X) | MethodOfAccountingCashInd |
Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contri Rcvd Rev And Expnss | $281,358 | ContriRcvdRevAndExpnssAmt |
| Dividends Rev And Expnss | $1,391,087 | DividendsRevAndExpnssAmt |
| Dividends Net Invst Incm | $1,391,087 | DividendsNetInvstIncmAmt |
| Net Gain Sale Ast Rev And Expnss | $1,660,066 | NetGainSaleAstRevAndExpnssAmt |
| Gross Sales Price | $6,170,716 | GrossSalesPriceAmt |
| Cap Gain Net Incm Net Invst Incm | $1,660,066 | CapGainNetIncmNetInvstIncmAmt |
| Incm Modifications Adj Net Incm | $6,033 | IncmModificationsAdjNetIncmAmt |
| Other Income Rev And Expnss | $6,600 | OtherIncomeRevAndExpnssAmt |
| Other Income Net Invst Incm | $0 | OtherIncomeNetInvstIncmAmt |
| Total Rev And Expnss | $3,339,111 | TotalRevAndExpnssAmt |
| Total Net Invst Incm | $3,051,153 | TotalNetInvstIncmAmt |
| Total Adj Net Incm | $6,033 | TotalAdjNetIncmAmt |
| Comp Ofcr Dir Trst Rev And Expnss | $0 | CompOfcrDirTrstRevAndExpnssAmt |
| Comp Ofcr Dir Trst Net Invst Incm | $0 | CompOfcrDirTrstNetInvstIncmAmt |
| Comp Ofcr Dir Trst Dsbrs Chrtbl | $0 | CompOfcrDirTrstDsbrsChrtblAmt |
| Legal Fees Rev And Expnss | $6,096 | LegalFeesRevAndExpnssAmt |
| Legal Fees Net Invst Incm | $0 | LegalFeesNetInvstIncmAmt |
| Legal Fees Dsbrs Chrtbl | $6,096 | LegalFeesDsbrsChrtblAmt |
| Accounting Fees Rev And Expnss | $30,089 | AccountingFeesRevAndExpnssAmt |
| Accounting Fees Net Invst Incm | $0 | AccountingFeesNetInvstIncmAmt |
| Accounting Fees Chrtbl Prps | $30,089 | AccountingFeesChrtblPrpsAmt |
| Other Prof Fees Rev And Expnss | $101,646 | OtherProfFeesRevAndExpnssAmt |
| Other Prof Fees Net Invst Incm | $88,323 | OtherProfFeesNetInvstIncmAmt |
| Other Prof Fees Dsbrs Chrtbl | $13,323 | OtherProfFeesDsbrsChrtblAmt |
| Interest Rev And Expnss | $4,142 | InterestRevAndExpnssAmt |
| Interest Net Invst Incm | $0 | InterestNetInvstIncmAmt |
| Interest Dsbrs Chrtbl | $0 | InterestDsbrsChrtblAmt |
| Taxes Rev And Expnss | $56,398 | TaxesRevAndExpnssAmt |
| Taxes Net Invst Incm | $35,359 | TaxesNetInvstIncmAmt |
| Taxes Dsbrs Chrtbl | $1,039 | TaxesDsbrsChrtblAmt |
| Trav Conf Meeting Rev And Expnss | $15,803 | TravConfMeetingRevAndExpnssAmt |
| Trav Conf Meeting Net Invst Incm | $0 | TravConfMeetingNetInvstIncmAmt |
| Trav Conf Meeting Dsbrs Chrtbl | $15,803 | TravConfMeetingDsbrsChrtblAmt |
| Other Expenses Rev And Expnss | $332,834 | OtherExpensesRevAndExpnssAmt |
| Other Expenses Net Invst Incm | $0 | OtherExpensesNetInvstIncmAmt |
| Other Expenses Dsbrs Chrtbl | $332,834 | OtherExpensesDsbrsChrtblAmt |
| Tot Opr Expenses Rev And Expnss | $547,008 | TotOprExpensesRevAndExpnssAmt |
| Tot Opr Expenses Net Invst Incm | $123,682 | TotOprExpensesNetInvstIncmAmt |
| Tot Opr Expenses Dsbrs Chrtbl | $399,184 | TotOprExpensesDsbrsChrtblAmt |
| Contri Paid Rev And Expnss | $2,150,250 | ContriPaidRevAndExpnssAmt |
| Contri Paid Dsbrs Chrtbl | $2,150,250 | ContriPaidDsbrsChrtblAmt |
| Total Expenses Rev And Expnss | $2,697,258 | TotalExpensesRevAndExpnssAmt |
| Total Expenses Net Invst Incm | $123,682 | TotalExpensesNetInvstIncmAmt |
| Total Expenses Dsbrs Chrtbl | $2,549,434 | TotalExpensesDsbrsChrtblAmt |
| Excess Revenue Over Expenses | $641,853 | ExcessRevenueOverExpensesAmt |
| Net Investment Income | $2,927,471 | NetInvestmentIncomeAmt |
| Adjusted Net Income | $6,033 | AdjustedNetIncomeAmt |
Form990 PF Balance Sheets Form990PFBalanceSheetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Sav And Temp Cash Invst BOY | $383,193 | SavAndTempCashInvstBOYAmt |
| Sav And Temp Cash Invst EOY | $204,648 | SavAndTempCashInvstEOYAmt |
| Sav And Temp Cash Invst EOYFMV | $204,648 | SavAndTempCashInvstEOYFMVAmt |
| Corporate Stock BOY | $34,837,751 | CorporateStockBOYAmt |
| Corporate Stock EOY | $35,440,583 | CorporateStockEOYAmt |
| Corporate Stock EOYFMV | $35,440,583 | CorporateStockEOYFMVAmt |
| Corporate Bonds BOY | $13,292,160 | CorporateBondsBOYAmt |
| Corporate Bonds EOY | $13,614,650 | CorporateBondsEOYAmt |
| Corporate Bonds EOYFMV | $13,614,650 | CorporateBondsEOYFMVAmt |
| Other Investments BOY | $14,795,058 | OtherInvestmentsBOYAmt |
| Other Investments EOY | $18,742,212 | OtherInvestmentsEOYAmt |
| Other Investments EOYFMV | $18,742,212 | OtherInvestmentsEOYFMVAmt |
| Other Assets BOY | $3,369,961 | OtherAssetsBOYAmt |
| Other Assets EOY | $4,006,057 | OtherAssetsEOYAmt |
| Other Assets EOYFMV | $4,006,057 | OtherAssetsEOYFMVAmt |
| Total Assets BOY | $66,678,123 | TotalAssetsBOYAmt |
| Total Assets EOY | $72,008,150 | TotalAssetsEOYAmt |
| Total Assets EOYFMV | $72,008,150 | TotalAssetsEOYFMVAmt |
| Total Liabilities BOY | $0 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $0 | TotalLiabilitiesEOYAmt |
| Org Does Not Follow FASB117 | Yes (X) | OrgDoesNotFollowFASB117Ind |
| Capital Stock BOY | $59,300,755 | CapitalStockBOYAmt |
| Capital Stock EOY | $59,300,755 | CapitalStockEOYAmt |
| Additional Paid In Capital BOY | $0 | AdditionalPaidInCapitalBOYAmt |
| Additional Paid In Capital EOY | $0 | AdditionalPaidInCapitalEOYAmt |
| Retained Earning BOY | $7,377,368 | RetainedEarningBOYAmt |
| Retained Earning EOY | $12,707,395 | RetainedEarningEOYAmt |
| Tot Net Ast Or Fund Balances BOY | $66,678,123 | TotNetAstOrFundBalancesBOYAmt |
| Tot Net Ast Or Fund Balances EOY | $72,008,150 | TotNetAstOrFundBalancesEOYAmt |
| Total Liabilities Net Ast BOY | $66,678,123 | TotalLiabilitiesNetAstBOYAmt |
| Total Liabilities Net Ast EOY | $72,008,150 | TotalLiabilitiesNetAstEOYAmt |
Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Net Ast Or Fund Balances BOY | $66,678,123 | TotNetAstOrFundBalancesBOYAmt |
| Excess Revenue Over Expenses | $641,853 | ExcessRevenueOverExpensesAmt |
| Other Increases | $5,298,086 | OtherIncreasesAmt |
| Subtotal | $72,618,062 | SubtotalAmt |
| Other Decreases | $609,912 | OtherDecreasesAmt |
| Tot Net Ast Or Fund Balances EOY | $72,008,150 | TotNetAstOrFundBalancesEOYAmt |
Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail
Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Property | PUBLICLY TRADED SECURITIES | PropertyDesc |
| Gross Sales Price | $6,170,716 | GrossSalesPriceAmt |
| Cost Or Other Basis | $4,510,650 | CostOrOtherBasisAmt |
| Gain Or Loss | $1,660,066 | GainOrLossAmt |
| Gains Minus Excess Or Losses | $1,660,066 | GainsMinusExcessOrLossesAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Capital Gain Net Income | $1,660,066 | CapitalGainNetIncomeAmt |
Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Income Excise Tax | $40,692 | InvestmentIncomeExciseTaxAmt |
| Tax Under Section511 | $0 | TaxUnderSection511Amt |
| Subtotal | $40,692 | SubtotalAmt |
| Subtitle A Tax | $0 | SubtitleATaxAmt |
| Tax Based On Investment Income | $40,692 | TaxBasedOnInvestmentIncomeAmt |
| Estimated Plus Ovpmt Incm Tx | $42,027 | EstimatedPlusOvpmtIncmTxAmt |
| Exempt Frgn Org Tax Wthld At Srce | $0 | ExemptFrgnOrgTaxWthldAtSrceAmt |
| Extsn Request Income Tax Paid | $0 | ExtsnRequestIncomeTaxPaidAmt |
| Backup Withholding Withheld | $0 | BackupWithholdingWithheldAmt |
| Total Payments And Credits | $42,027 | TotalPaymentsAndCreditsAmt |
| Es Penalty | $0 | EsPenaltyAmt |
| Overpayment | $1,335 | OverpaymentAmt |
| Applied To ES Tax | $1,335 | AppliedToESTaxAmt |
| Refund | $0 | RefundAmt |
Statements Regarding Acty StatementsRegardingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Legislative Political Acty | 0 | LegislativePoliticalActyInd |
| More Than100 Spent | 0 | MoreThan100SpentInd |
| Form1120 POL Filed | 0 | Form1120POLFiledInd |
| Section4955 Organization Tax | $0 | Section4955OrganizationTaxAmt |
| Section4955 Managers Tax | $0 | Section4955ManagersTaxAmt |
| Tax Reimbursed | $0 | TaxReimbursedAmt |
| Activities Not Previously Rpt | 0 | ActivitiesNotPreviouslyRptInd |
| Changes To Articles Or Bylaws | 0 | ChangesToArticlesOrBylawsInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Organization Dissolved Etc | 0 | OrganizationDissolvedEtcInd |
| Section508e Rqr Satisfied | Yes (1) | Section508eRqrSatisfiedInd |
| At Least5000 In Assets | Yes (1) | AtLeast5000InAssetsInd |
| Org Report Or Register State | MA | OrgReportOrRegisterStateCd |
| Form990 PF Filed With Atty Gen | Yes (1) | Form990PFFiledWithAttyGenInd |
| Private Operating Foundation | 0 | PrivateOperatingFoundationInd |
| New Substantial Contributors | 0 | NewSubstantialContributorsInd |
| Own Controlled Entity | Yes (1) | OwnControlledEntityInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Comply With Public Insp Rqr | Yes (1) | ComplyWithPublicInspRqrInd |
| Website Address | HTTPS://HRIA.ORG/TMF/HOOD/ | WebsiteAddressTxt |
| Individual With Books | AAFCPAS INC | IndividualWithBooksNm |
| Phone | 5083669100 | PhoneNum |
Location Of Books US Address LocationOfBooksUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 50 WASHINGTON STREET | AddressLine1Txt |
| City | WESTBOROUGH | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 01581 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Foreign Accounts Question | 0 | ForeignAccountsQuestionInd |
Statements Regarding Acty4720 StatementsRegardingActy4720Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Sale Or Exch Disqualified Prsn | 0 | SaleOrExchDisqualifiedPrsnInd |
| Brrw Or Lend Disqualified Prsn | 0 | BrrwOrLendDisqualifiedPrsnInd |
| Furn Goods Disqualified Prsn | 0 | FurnGoodsDisqualifiedPrsnInd |
| Pay Comp Disqualified Prsn | Yes (1) | PayCompDisqualifiedPrsnInd |
| Transfer Ast Disqualified Prsn | 0 | TransferAstDisqualifiedPrsnInd |
| Payment To Government Official | 0 | PaymentToGovernmentOfficialInd |
| Acts Fail To Qlfy As Exceptions | 0 | ActsFailToQlfyAsExceptionsInd |
| Uncorrected Prior Acts | 0 | UncorrectedPriorActsInd |
| Undistributed Income PY | 0 | UndistributedIncomePYInd |
| Business Holdings | Yes (1) | BusinessHoldingsInd |
| Excess Business Holdings | 0 | ExcessBusinessHoldingsInd |
| Jeopardy Investments | 0 | JeopardyInvestmentsInd |
| Uncorrected PY Jeopardy Invst | 0 | UncorrectedPYJeopardyInvstInd |
| Influence Legislation | 0 | InfluenceLegislationInd |
| Influence Election | 0 | InfluenceElectionInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Noncharitable Purpose | 0 | NoncharitablePurposeInd |
| Transactions Fail To Qlfy As Exc | 0 | TransactionsFailToQlfyAsExcInd |
| Maintained Expenditure Rspns | Yes (1) | MaintainedExpenditureRspnsInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp
Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (7 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | TitleTitleTxt | Average Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRt | CompensationCompensationAmt | Employee Benefit ProgramEmployeeBenefitProgramAmt | Expense Account Other AllwncExpenseAccountOtherAllwncAmt |
|---|---|---|---|---|---|---|---|---|
| NEIL SMILEY | ||||||||
| 2 BOYLSTON STREET 4TH FLOOR | BOSTON | MA | 02116 | PRESIDENT AND TREASURER | 1.00 | $0 | $0 | $0 |
| JOHN O PARKER JR | ||||||||
| 2 BOYLSTON STREET 4TH FLOOR | BOSTON | MA | 02116 | VICE PRESIDENT AND CLERK | 1.00 | $0 | $0 | $0 |
| ROBERT C BOUTWELL | ||||||||
| 2 BOYLSTON STREET 4TH FLOOR | BOSTON | MA | 02116 | TRUSTEE | 1.00 | $0 | $0 | $0 |
| BARBARA BULA | ||||||||
| 2 BOYLSTON STREET 4TH FLOOR | BOSTON | MA | 02116 | TRUSTEE | 1.00 | $0 | $0 | $0 |
| BRENDON BULA | ||||||||
| 2 BOYLSTON STREET 4TH FLOOR | BOSTON | MA | 02116 | TRUSTEE | 1.00 | $0 | $0 | $0 |
| ELIZABETH HOOD | ||||||||
| 2 BOYLSTON STREET 4TH FLOOR | BOSTON | MA | 02116 | TRUSTEE | 1.00 | $0 | $0 | $0 |
| CLAY SMILEY | ||||||||
| 2 BOYLSTON STREET 4TH FLOOR | BOSTON | MA | 02116 | TRUSTEE | 1.00 | $0 | $0 | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Comp Of Hghst Pd Empl Or NONE | NONE | CompOfHghstPdEmplOrNONETxt |
| Other Employee Paid Over50k | 0 | OtherEmployeePaidOver50kCnt |
Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Service TypeServiceTypeTxt | CompensationCompensationAmt |
|---|---|---|---|---|---|
| HEALTH RESOURCES IN ACTION | |||||
| 2 BOYLSTON STREET 4TH FLOOR | BOSTON | MA | 02116 | ADMINISTRATIVE FEES | $256,489 |
| PRIME BUCHHOLZ | |||||
| 273 CORPORATE DRIVE SUITE 250 | PORTSMOUTH | NH | 03801 | INVESTMENT ADVISORY SERVICES | $75,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contractor Paid Over50k | 0 | ContractorPaidOver50kCnt |
Sum Of Program Related Invst SumOfProgramRelatedInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description1 | MULBERRY BIOTHERAPEUTICS INC. - WELLESLEY, MACONVERTIBLE PROMISSORY NOTE | Description1Txt |
| Expenses1 | $250,000 | Expenses1Amt |
| Description2 | PLAKOUS THERAPEUTICS - WINSTOM-SALEM, NCCONVERTIBLE PROMISSORY NOTE | Description2Txt |
| Expenses2 | $250,000 | Expenses2Amt |
| All Other Program Rltd Invst Tot | $425,000 | AllOtherProgramRltdInvstTotAmt |
| Total | $925,000 | TotalAmt |
Minimum Investment Return MinimumInvestmentReturnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Average Monthly FMV Of Sec | $53,138,962 | AverageMonthlyFMVOfSecAmt |
| Average Monthly Cash Balances | $401,650 | AverageMonthlyCashBalancesAmt |
| FMV All Other Noncharitable Ast | $13,979,158 | FMVAllOtherNoncharitableAstAmt |
| Total FMV Of Unused Assets | $67,519,770 | TotalFMVOfUnusedAssetsAmt |
| Reduction Claimed | $0 | ReductionClaimedAmt |
| Acquisition Indebtedness | $0 | AcquisitionIndebtednessAmt |
| Adjusted Total FMV Of Unused Ast | $67,519,770 | AdjustedTotalFMVOfUnusedAstAmt |
| Cash Deemed Charitable | $1,012,797 | CashDeemedCharitableAmt |
| Net Vl Noncharitable Assets | $66,506,973 | NetVlNoncharitableAssetsAmt |
| Minimum Investment Return | $3,325,349 | MinimumInvestmentReturnAmt |
Distributable Amount DistributableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Minimum Investment Return | $3,325,349 | MinimumInvestmentReturnAmt |
| Tax Based On Investment Income | $40,692 | TaxBasedOnInvestmentIncomeAmt |
| Total Tax | $40,692 | TotalTaxAmt |
| Distributable Before Adj | $3,284,657 | DistributableBeforeAdjAmt |
| Recoveries Qualfied Distri | $156,033 | RecoveriesQualfiedDistriAmt |
| Distributable Before Ded | $3,440,690 | DistributableBeforeDedAmt |
| Deduction From Distributable | $0 | DeductionFromDistributableAmt |
| Distributable As Adjusted | $3,440,690 | DistributableAsAdjustedAmt |
PF Qualifying Distributions PFQualifyingDistributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expenses And Contributions | $2,549,434 | ExpensesAndContributionsAmt |
| Program Related Invst Total | $925,000 | ProgramRelatedInvstTotalAmt |
| Qualifying Distributions | $3,474,434 | QualifyingDistributionsAmt |
Undistributed Income UndistributedIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Distributable As Adjusted | $3,440,690 | DistributableAsAdjustedAmt |
| Undistributed Income PY | $3,301,908 | UndistributedIncomePYAmt |
| Total For Prior Years | $0 | TotalForPriorYearsAmt |
| Total Excess Distribution Cyov | $0 | TotalExcessDistributionCyovAmt |
| Qualifying Distributions | $3,474,434 | QualifyingDistributionsAmt |
| Applied To Year1 | $3,301,908 | AppliedToYear1Amt |
| Applied To Prior Years | $0 | AppliedToPriorYearsAmt |
| Treated As Distri From Corpus | $0 | TreatedAsDistriFromCorpusAmt |
| Applied To Current Year | $172,526 | AppliedToCurrentYearAmt |
| Remaining Distri From Corpus | $0 | RemainingDistriFromCorpusAmt |
| Excess Distri Cyov App CY Corpus | $0 | ExcessDistriCyovAppCYCorpusAmt |
| Excess Distribution Cyov App CY | $0 | ExcessDistributionCyovAppCYAmt |
| Total Corpus | $0 | TotalCorpusAmt |
| Prior Year Undistributed Incm | $0 | PriorYearUndistributedIncmAmt |
| Prior Year Deficiency Or Tax | $0 | PriorYearDeficiencyOrTaxAmt |
| Taxable1 | $0 | Taxable1Amt |
| Taxable2 | $0 | Taxable2Amt |
| Undistributed Income CY | $3,268,164 | UndistributedIncomeCYAmt |
| Corpus Distri170b1 E Or4942g3 | $0 | CorpusDistri170b1EOr4942g3Amt |
| Excess Distri Cyov From Yr5 | $0 | ExcessDistriCyovFromYr5Amt |
| Excess Distri Cyov To Next Yr | $0 | ExcessDistriCyovToNextYrAmt |
Supplementary Information SupplementaryInformationGrp
Application Submission Info ApplicationSubmissionInfoGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Recipient Person | CHARLENE MANCUSI DIRECTOR HRIA | RecipientPersonNm |
Recipient US Address RecipientUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2 BOYLSTON STREET 4TH FLOOR | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02116 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Recipient Phone | 6176959439 | RecipientPhoneNum |
| Recipient Email Address | CMANCUSI@HRIA.ORG | RecipientEmailAddressTxt |
| Form And Info And Materials | APPLICATION FORMS AVAILABLE AT WWW.TMFGRANTS.ORG/HOOD | FormAndInfoAndMaterialsTxt |
| Submission Deadlines | ANNUALLY MARCH AND OCTOBER | SubmissionDeadlinesTxt |
| Restrictions On Awards | RESTRICTED TO PEDIATRIC RESEARCH | RestrictionsOnAwardsTxt |
Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (27 entries)
| Address Line1RecipientUSAddress/AddressLine1Txt | CityRecipientUSAddress/CityNm | State AbbreviationRecipientUSAddress/StateAbbreviationCd | ZIPRecipientUSAddress/ZIPCd | Recipient Foundation StatusRecipientFoundationStatusTxt | Grant Or Contribution PurposeGrantOrContributionPurposeTxt | AmtAmt | Address Line2RecipientUSAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|
| FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH | |||||||
| 11400 ROCKVILLE PIKE SUITE 600 | NORTH BETHESDA | MD | 20852 | PC | SPECIAL GRANT SUPPORT FOR THE PEDIATRIC MEDICAL DEVICE PUBLIC PRIVATE PARTNERSHIP (DESIGN PHASE) | $15,000 | |
| BETH ISRAEL DEACONESS MEDICAL CENTER | |||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | PC | SPECIAL GRANT SUPPORT FOR THE ENDOWED CHAIR FOR DR. STEVEN FREEDMAN, IN HONOR OF JUDY HOOD | $100,000 | |
| HARVARD MEDICAL SCHOOL | |||||||
| PO BOX 415649 | BOSTON | MA | 02241 | PC | CHARLES AWARD IN PEDIATRIC HEALTH [CHARLES H. HOOD ALUMNI RECOGNITION FOR LEADERSHIP, EXCELLENCE AND SERVICE] - DETECTING PEDIATRIC GROWTH DISORDERS USING AI | $100,000 | |
| TRUSTEES OF DARTMOUTH COLLEGE | |||||||
| OFFICE OF SPONSORED PROJECTS 11 | HANOVER | NH | 03755 | PC | MAJOR GRANT - DECREASING HARMS AND IMPROVING CHILD HEALTH: AN INTERVENTION TO REDUCE INAPPROPRIATE USE OF ANTIPSYCHOTICS AND POLYPHARMACY | $70,250 | ROPE FERRY ROAD |
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | |||||||
| C/O BANK OF AMERICA 222 BROADWAY ST | NEW YORK | NY | 10038 | PC | CHILD HEALTH RESEARCH AWARD - THE ROLE OF MARCO IN PEDIATRIC CANCER | $82,500 | |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - THE ROLE OF AIRWAY NEURONS IN CHILDHOOD ASTHMA | $82,500 | STREET |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - DEVELOPING A BROADLY APPLICABLE THERAPEUTIC STRATEGY TO REVERSE SYMPTOMS OF NEURODEVELOPMENTAL DISORDERS | $82,500 | STREET |
| YALE SCHOOL OF MEDICINE | |||||||
| PO BOX 208239 | NEW HAVEN | CT | 06520 | PC | CHILD HEALTH RESEARCH AWARD - NEURAL MARKERS OF CHRONIC, PERSISTENT PEDIATRIC IRRITABILITY | $82,500 | |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - SPATIAL MAPPING OF MALIGNANT SUBPOPULATIONS ENABLING NEURON-GLIOMA CIRCUIT INTERACTIONS IN DIPG | $82,500 | STREET |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - DISSECTING IMMUNE-STROMAL INTERACTIONS TO DISCOVER NOVEL STRATEGY TO MODULATE INFLAMMATION | $82,500 | STREET |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - THE ROLE AND MECHANISM OF MAKORIN RING FINGER PROTEIN 3 IN CHILDREN WITH DELAYED PUBERTY | $40,000 | STREET |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 1295 BOYLSTON | BOSTON | MA | 02215 | PC | CHILD HEALTH RESEARCH AWARD - MACHINE-LEARNING PREDICTION MODEL FOR PERSONALIZED URINARY TRACT INFECTION CARE IN CHILDREN | $40,000 | STREET 4TH FL |
| BROWN UNIVERSITY | |||||||
| CASHIER OFFICE BOX 1997 69 BROWN | PROVIDENCE | RI | 02912 | PC | CHILD HEALTH RESEARCH AWARD - DEVELOPMENT OF A HIGH EFFICACY NON-CAPSID NOROVIRUS VACCINE | $40,000 | STREET 2ND FLOOR |
| HARVARD MEDICAL SCHOOL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - DECIPHERING MECHANISMS LINKING CHILDHOOD VIRAL INFECTION AND ASTHMA DEVELOPMENT | $40,000 | STREET |
| WORCESTER POLYTECHNIC INSTITUTE | |||||||
| C/O TD BANK 370 MAIN ST | WORCESTER | MA | 01608 | PC | CHILD HEALTH RESEARCH AWARD - ROLE OF HETEROTRIMERIC G PROTEINS IN CILIA ASSEMBLY AND PATHOGENESIS OF NEURODEVELOPMENTAL DISORDERS | $40,000 | |
| YALE UNIVERSITY | |||||||
| C/O BANK OF AMERICA MERRILL | NEW YORK | NY | 10001 | PC | CHILD HEALTH RESEARCH AWARD - DIAGNOSIS OF PEDIATRIC MALIGNANCIES USING DEVELOPMENTAL MAPPING AND MACHINE LEARNING | $40,000 | LYNCH100 WEST 33RD STREET |
| YALE UNIVERSITY | |||||||
| C/O BANK OF AMERICA MERRILL | NEW YORK | NY | 10001 | PC | CHILD HEALTH RESEARCH AWARD - SUPPORTING REFUGEE MENTAL HEALTH THROUGH TRANSLATION OF EVALUATIVE INSTRUMENTS AND THROUGH A PREVENTIVE MENTAL HEALTH INTERVENTION | $100,000 | LYNCH100 WEST 33RD STREET |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| BANK OF AMERICA NA PO BOX 414876 | BOSTON | MA | 02241 | PC | CHILD HEALTH RESEARCH AWARD - TACKLING PULMONARY HYPOPLASIA WITH GENETIC, EPIGENETIC AND STEM CELL APPROACHES. | $100,000 | |
| BOSTON COLLEGE | |||||||
| 140 COMMONWEALTH AVE 129 LAKE ST | CHESTNUT HILL | MA | 02467 | PC | CHILD HEALTH RESEARCH AWARD - IMPROVING CHILDHOOD TUBERCULOSIS TREATMENT OUTCOMES AND POST-TB LUNG FUNCTIONING AND QUALITY OF LIFE IN RURAL SOUTH AFRICA | $100,000 | 440 |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - IDENTIFYING EEG-BASED BIOMARKERS OF LANGUAGE GROWTH IN PRESCHOOL-AGED CHILDREN WITH DOWN SYNDROME | $100,000 | STREET |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - CHARACTERIZING THE ROLE OF TWO SUBCORTICAL NUCLEI IN PREFRONTAL REGULATION OF ATTENTION | $100,000 | STREET |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - POSTNATAL EXPOSURE TO HYPEROXIA CAUSES MALADAPTATION OF THE PREMATURE INTESTINE | $100,000 | STREET |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - ROLE OF XENOBIOTIC PATHWAYS TO MODULATE INTESTINAL EPITHELIAL METABOLISM, AS POSSIBLE TARGETS FOR OBESITY AND DIABETES | $100,000 | STREET |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - THE ROLE OF MESENCHYMAL STEM CELLS TO ENHANCE IMMUNE FUNCTION IN A MODEL OF NEONATAL INFECTION | $100,000 | STREET |
| DARTMOUTH-HITCHCOCK CLINIC | |||||||
| RESEARCH OPERATIONS 1 MEDICAL | LEBANON | NH | 03756 | PC | CHILD HEALTH RESEARCH AWARD - EVALUATING MECHANISMS OF ENVIRONMENTAL CHEMICAL EXPOSURE WITH DEVELOPING ZEBRAFISH URINARY SYSTEM | $130,000 | CENTER DRIVE |
| MASSACHUSETTS EYE AND EAR INFIRMARY | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - ADVANCING THE RETINOIC ACID SIGNALING ACTIVATOR AS A NOVEL THERAPEUTIC IN MOUSE MODELS OF RETINAL DEGENERATION | $100,000 | STREET |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - DECIPHERING THE MECHANISM UNDERLYING SHORT- AND LONG-TERM AIRWAY HYPERRESPONSIVENESS FOLLOWING EARLY-LIFE RSV INFECTION | $100,000 | STREET |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grant Or Contri Pd Dur Yr | $2,150,250 | TotalGrantOrContriPdDurYrAmt |
Grant Or Contri Apprv For Fut GrantOrContriApprvForFutGrp (11 entries)
| Address Line1RecipientUSAddress/AddressLine1Txt | Address Line2RecipientUSAddress/AddressLine2Txt | CityRecipientUSAddress/CityNm | State AbbreviationRecipientUSAddress/StateAbbreviationCd | ZIPRecipientUSAddress/ZIPCd | Recipient Foundation StatusRecipientFoundationStatusTxt | Grant Or Contribution PurposeGrantOrContributionPurposeTxt | AmtAmt |
|---|---|---|---|---|---|---|---|
| YALE UNIVERSITY | |||||||
| C/O BANK OF AMERICA MERRILL | LYNCH100 WEST 33RD STREET | NEW YORK | NY | 10001 | PC | CHILD HEALTH RESEARCH AWARD - SUPPORTING REFUGEE MENTAL HEALTH THROUGH TRANSLATION OF EVALUATIVE INSTRUMENTS AND THROUGH A PREVENTIVE MENTAL HEALTH INTERVENTION | $100,000 |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| BANK OF AMERICA NA PO BOX 414876 | BOSTON | MA | 02241 | PC | CHILD HEALTH RESEARCH AWARD - TACKLING PULMONARY HYPOPLASIA WITH GENETIC, EPIGENETIC AND STEM CELL APPROACHES. | $100,000 | |
| BOSTON COLLEGE | |||||||
| 140 COMMONWEALTH AVE 129 LAKE ST | 440 | CHESTNUT HILL | MA | 02467 | PC | CHILD HEALTH RESEARCH AWARD - IMPROVING CHILDHOOD TUBERCULOSIS TREATMENT OUTCOMES AND POST-TB LUNG FUNCTIONING AND QUALITY OF LIFE IN RURAL SOUTH AFRICA | $100,000 |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | STREET | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - IDENTIFYING EEG-BASED BIOMARKERS OF LANGUAGE GROWTH IN PRESCHOOL-AGED CHILDREN WITH DOWN SYNDROME | $100,000 |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | STREET | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - CHARACTERIZING THE ROLE OF TWO SUBCORTICAL NUCLEI IN PREFRONTAL REGULATION OF ATTENTION | $100,000 |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | STREET | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - POSTNATAL EXPOSURE TO HYPEROXIA CAUSES MALADAPTATION OF THE PREMATURE INTESTINE | $100,000 |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | STREET | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - ROLE OF XENOBIOTIC PATHWAYS TO MODULATE INTESTINAL EPITHELIAL METABOLISM, AS POSSIBLE TARGETS FOR OBESITY AND DIABETES | $100,000 |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | STREET | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - THE ROLE OF MESENCHYMAL STEM CELLS TO ENHANCE IMMUNE FUNCTION IN A MODEL OF NEONATAL INFECTION | $100,000 |
| DARTMOUTH-HITCHCOCK CLINIC | |||||||
| RESEARCH OPERATIONS 1 MEDICAL | CENTER DRIVE | LEBANON | NH | 03756 | PC | CHILD HEALTH RESEARCH AWARD - EVALUATING MECHANISMS OF ENVIRONMENTAL CHEMICAL EXPOSURE WITH DEVELOPING ZEBRAFISH URINARY SYSTEM | $70,000 |
| MASSACHUSETTS EYE AND EAR INFIRMARY | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | STREET | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - ADVANCING THE RETINOIC ACID SIGNALING ACTIVATOR AS A NOVEL THERAPEUTIC IN MOUSE MODELS OF RETINAL DEGENERATION | $100,000 |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| C/O BANK OF AMERICA 100 FEDERAL | STREET | BOSTON | MA | 02110 | PC | CHILD HEALTH RESEARCH AWARD - DECIPHERING THE MECHANISM UNDERLYING SHORT- AND LONG-TERM AIRWAY HYPERRESPONSIVENESS FOLLOWING EARLY-LIFE RSV INFECTION | $100,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grant Or Contri Apprv Fut | $1,070,000 | TotalGrantOrContriApprvFutAmt |
Analysis Income Producing Acty AnalysisIncomeProducingActyGrp
Dividends And Interest From Sec Dtl DividendsAndInterestFromSecDtl
| Field | Value | IRS element (for citing) |
|---|---|---|
| Exclusion | 14 | ExclusionCd |
| Exclusion | $1,391,087 | ExclusionAmt |
Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Exclusion | 18 | ExclusionCd |
| Exclusion | $1,660,066 | ExclusionAmt |
Other Revenue Described OtherRevenueDescribedGrp (2 entries)
| DescDesc | Related Or Exempt Function IncmRelatedOrExemptFunctionIncmAmt |
|---|---|
| RETURNED GRANT FUNDS | $6,033 |
| OTHER INVESTMENT INCOME | $567 |
Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Unrelated Business Taxbl Incm | $0 | UnrelatedBusinessTaxblIncmAmt |
| Exclusion | $3,051,153 | ExclusionAmt |
| Related Or Exempt Function Incm | $6,600 | RelatedOrExemptFunctionIncmAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Income Producing Acty | $3,057,753 | TotalIncomeProducingActyAmt |
Rln Of Acty To Accom Of Exmpt Prps RlnOfActyToAccomOfExmptPrpsGrp
Rln Of Acty To Accom Of Exmpt Prps RlnOfActyToAccomOfExmptPrpsGrp (2 entries)
| Line NumberLineNumberTxt | Relationship StatementRelationshipStatementTxt |
|---|---|
| 11A | EXCESS FUNDS RETURNED FROM GRANTS PREVIOUSLY PAID OUT. |
| 11B | SETTLEMENT PROCEEDS ON INVESTMENTS |
Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trnsfr Of Cash To Nonchrtbl EO | 0 | TrnsfrOfCashToNonchrtblEOInd |
| Trnsfr Other Asset Nonchrtbl EO | 0 | TrnsfrOtherAssetNonchrtblEOInd |
| Sales Or Exchanges Of Assets | 0 | SalesOrExchangesOfAssetsInd |
| Purchase Of Assets Nonchrtbl EO | 0 | PurchaseOfAssetsNonchrtblEOInd |
| Rental Of Facilities Oth Assets | 0 | RentalOfFacilitiesOthAssetsInd |
| Reimbursement Arrangements | 0 | ReimbursementArrangementsInd |
| Loans Or Loan Guarantees | 0 | LoansOrLoanGuaranteesInd |
| Performance Of Services Etc | 0 | PerformanceOfServicesEtcInd |
| Sharing Of Facilities Etc | 0 | SharingOfFacilitiesEtcInd |
| Relationships Nonchrtbl EO | 0 | RelationshipsNonchrtblEOInd |
Schedule B IRS990ScheduleB
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization501c3 Exempt PF | Yes (X) | Organization501c3ExemptPFInd |
| General Rule | Yes (X) | GeneralRuleInd |
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | 1 | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ESTATE OF JUDITH HOOD | BusinessNameLine1Txt |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | BANK OF AMERICA 1025 MAIN ST | AddressLine1Txt |
| City | WALTHAM | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02451 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | $281,358 | TotalContributionsAmt |
| Person Contribution | Yes (X) | PersonContributionInd |
Accounting Fees Schedule AccountingFeesSchedule
Accounting Fees Detail AccountingFeesDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Category | ACCOUNTING & TAX PREPARATION FEES | CategoryTxt |
| Amt | $30,089 | Amt |
| Net Investment Income | $0 | NetInvestmentIncomeAmt |
| Disbursements Charitable Prps | $30,089 | DisbursementsCharitablePrpsAmt |
All Oth Prog Rltd Investments Sch AllOthProgRltdInvestmentsSch
All Other Program Related Invst AllOtherProgramRelatedInvstGrp (4 entries)
| DescDesc | AmtAmt |
|---|---|
| NURTURE GENOMICS - CAMBRIDGE, MA SIMPLE AGREEMENT FOR FUTURE EQUITY | $250,000 |
| ARGUS COGNITIVE, INC. - LEBANON, NH SIMPLE AGREEMENT FOR FUTURE EQUITY | $25,000 |
| SMOLTAP, INC. - PROVIDENCE, RI SERIES SEED PREFERRED STOCK INVESTMENT | $100,000 |
| PRAPELA, LLC - BIDDEFORD, ME CONVERTIBLE PROMISSORY NOTE | $50,000 |
Expenditure Responsibility Stmt ExpenditureResponsibilityStmt
Expenditure Responsibility ExpenditureResponsibilityGrp (25 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | GrantGrantDt | GrantGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Expended By GranteeExpendedByGranteeAmt | Any Diversion By GranteeAnyDiversionByGranteeTxt | Dates Of Reports By GranteeDatesOfReportsByGranteeTxt | VerificationVerificationDt | Results Of VerificationResultsOfVerificationTxt | Address Line2USAddress/AddressLine2Txt | Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | Province Or StateForeignAddress/ProvinceOrStateNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 149 MEDICAL INC | |||||||||||||||||
| 1173 MAIN STREET | BOLTON | MA | 01740 | 2020-04-17 | $150,000 | TO SUPPORT THE PRE-COMMERCIALIZATION DEVELOPMENT OF A MONITOR THAT MEASURES REAL-TIME BRAIN HEMODYNAMICS AND METABOLISM IN PRETERM NEWBORNS, IN AN ATTEMPT TO CHANGE THE STANDARD OF CARE BY IMPROVING LIVES, REDUCING MEDICAL ERRORS, AND REDUCING OVERALL HEALTHCARE COSTS, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. | $150,000 | NONE, SEE BELOW | PRI REPORT - 8/16/2023 | 2022-06-10 | 149 MEDICAL DISSOLVED IN 2023. PRIOR TO THIS, THE TRUSTEES MET WITH 149 MEDICAL, INC. ON A REGULAR BASIS, ATTENDED BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. | ||||||
| ALDATU BIOSCIENCES INC | |||||||||||||||||
| C/O ARSENAL LAB SPACE 201 DEXTER | WATERTOWN | MA | 02472 | 2016-02-23 | $100,000 | TO SUPPORT THE USE AND DEVELOPMENT OF A SIMPLE, RAPID, THERMOSTABLE KIT THAT IDENTIFIES CLINICALLY ACTIONABLE HIV MUTATIONS FOUND IN PATIENTS FAILING A FIRST-LINE DRUG REGIMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. | $100,000 | NONE, SEE BELOW | PRI REPORTS - 5/26/2023, 6/12/2023, 12/12/2023, 6/12/2024 | 2017-12-15 | THE TRUSTEES MEET WITH ALDATU BIOSCIENCES, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. | AVE | |||||
| ANIDA PHARMA INC | |||||||||||||||||
| 155 BROOKLINE STREET SUITE 005 | CAMBRIDGE | MA | 02139 | 2020-12-21 | $250,000 | TO SUPPORT THE PRECLINICAL DEVELOPMENT OF A PREVENTATIVE TREATMENT FOR RETINOPATHY OF PREMATURITY, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. | $250,000 | NONE, SEE BELOW | PRI REPORTS - 7/21/2023, 8/23/2023, 6/24/2024 | 2023-07-21 | THE TRUSTEES MEET WITH ANIDA PHARMA, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| ARGUS COGNITIVE INC | |||||||||||||||||
| DARTMOUTH REGIONAL TECHNICAL CENTER | LEBANON | NH | 03766 | 2021-05-10 | $250,000 | TO SUPPORT THE DEVELOPMENT AND CLINICAL TESTING OF THE CORPORATION'S CLINICAL DECISION SUPPORT SOFTWARE FOR USE IN PEDIATRIC INDICATIONS, INCLUDING AUTISM AND PEDIATRIC CARDIOLOGY, THEREBY SUPPORTING RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED AND LESSENING THE BURDEN OF THE GOVERNMENT. | $250,000 | NONE, SEE BELOW | PRI REPORTS -2/22/2023,8/23/2023,9/7/2023,3/5/2024,5/18/2024,6/6/2024,7/3/20 | 2023-08-23 | THE TRUSTEES MEET WITH ARGUS COGNITIVE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | 16 CAVENDISH | |||||
| ARGUS COGNITIVE INC | |||||||||||||||||
| DARTMOUTH REGIONAL TECHNICAL CENTER | LEBANON | NH | 03766 | 2023-07-10 | $25,000 | TO SUPPORT THE DEVELOPMENT AND CLINICAL TESTING OF THE CORPORATION'S CLINICAL DECISION SUPPORT SOFTWARE FOR USE IN PEDIATRIC INDICATIONS, INCLUDING AUTISM AND PEDIATRIC CARDIOLOGY, THEREBY SUPPORTING RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED AND LESSENING THE BURDEN OF THE GOVERNMENT. | $25,000 | NONE, SEE BELOW | PRI REPORTS -2/22/2023,8/23/2023,9/7/2023,3/5/2024,5/18/2024,6/6/2024,7/3/20 | 2024-09-13 | THE TRUSTEES MEET WITH ARGUS COGNITIVE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | 16 CAVENDISH | |||||
| BIOROSA TECHNOLOGIES INC | |||||||||||||||||
| 63 BAKER STREET | BELMONT | MA | 02478 | 2020-07-15 | $150,000 | TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. | $150,000 | NONE, SEE BELOW | PRI REPORTS - 8/14/2023, 10/30/2023, 1/8/2024, 9/24/2024 | 2021-07-16 | THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| BIOROSA TECHNOLOGIES INC | |||||||||||||||||
| 63 BAKER STREET | BELMONT | MA | 02478 | 2022-11-15 | $100,000 | TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. | $100,000 | NONE, SEE BELOW | PRI REPORTS - 8/14/2023, 10/30/2023, 1/8/2024, 9/24/2024 | 2023-08-14 | THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| BREEGI SCIENTIFIC INC | |||||||||||||||||
| 120 BEDFORD ROAD | WOBURN | MA | 01801 | 2017-06-26 | $250,000 | THE FUNDS WILL BE USED TO CONDUCT A THOROUGH CLINICAL ASSESSMENT OF BSI'S NOVEL NEONATAL INTENSIVE CARE INCUBATOR "(NICI)" IN HONDURAS AND ZAMBIA AND TO AID THE COMMERCIALIZATION EFFORTS OF THIS LIFE-SAVING MEDICAL DEVICE, THEREBY LESSENING THE BURDEN OF THE GOVERNMENT AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. | $250,000 | NONE, SEE BELOW | PRI REPORTS - 1/5/2023, 8/24/2023, 6/3/2024, 10/1/2024 | 2021-08-02 | THE TRUSTEES MEET WITH BREEGI SCIENTIFIC, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| DECK THERAPEUTICS INC | |||||||||||||||||
| 8 HARVARD LANE | HASTINGS ON HUDSON | NY | 10706 | 2022-10-12 | $200,000 | TO SUPPORT THE DEVELOPMENT OF SEMI-SYNTHETIC OMEGA-3 COMPOUNDS THAT BLOCK MULTIPLE CELL-DEATH PATHWAYS INDUCED BY HYPOXIC-ISCHEMIC INJURY IN NEONATES. | $200,000 | NONE, SEE BELOW | PRI REPORTS - 3/1/2023, 6/20/2023, 7/24/2023, 10/19/2023, 5/2/2023 | 2023-05-02 | THE TRUSTEES MEET WITH DECK THERAPEUTICS, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| INKSPACE IMAGING INC | |||||||||||||||||
| 5635 W LAS POSITAS BLVD STE 403/404 | PLEASANTON | CA | 94588 | 2022-10-20 | $250,000 | TO SUPPORT THE DEVELOPMENT OF FLEXIBLE, LIGHTWEIGHT, LOW COST MRI COILS DESIGNED SPECIFICALLY FOR PEDIATRIC PATIENTS, WHILE ALSO IMPROVING IMAGE RESOLUTION AND REDUCING MRI FAILURE RATES. | $250,000 | NONE, SEE BELOW | PRI REPORTS - 6/5/2023, 8/12/2024 | 2024-08-12 | THE TRUSTEES MEET WITH INKSPACE IMAGING, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| MESENTECH INC | |||||||||||||||||
| 2020-11-02 | $250,000 | TO SUPPORT THE ADVANCEMENT OF SCIENCE AND PROMOTION OF HEALTH THROUGH THE PRECLINICAL RESEARCH OF ANABOLIC BONE THERAPEUTICS THAT CAN INCREASE BONE MASS TO STRENGTHEN THE SKELETON AND THE DEVELOPMENT OF A DRUG DELIVERY SYSTEM TO BE INITIALLY APPLIED TO TWO PEDIATRIC RARE DISEASES: OSTEOGENESIS IMPERFECTA AND DUCHENNE MUSCULAR DYSTROPHY. | $250,000 | NONE, SEE BELOW | PRI REPORTS - 1/27/2023, 7/3/2023, 9/12/2023, 10/2023, 6/4/2024, 6/5/2024 | 2022-08-26 | THE TRUSTEES MEET WITH MESENTECH, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | 2222 HEALTH SCIENCES RD | VANCOUVER | BRITISH COLUMBIA | CA | V6T2B9 | |||||
| MULBERRY BIOTHERAPEUTICS INC | |||||||||||||||||
| 40 WALNUT STREET SUITE 301 | WELLESLEY | MA | 02481 | 2023-12-26 | $250,000 | TO SUPPORT PRECLINICAL WORK RELATING TO THE DEVELOPMENT OF A BACTERIA-MEDIATED THERAPY FOR NEUROFIBROMATOSIS TYPE 2. | $0 | NONE, SEE BELOW | PRI REPORT - 6/11/2024 | 2024-06-11 | THE TRUSTEES MEET WITH MULBERRY BIOTHERAPEUTICS INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| NICOLETTE INC | |||||||||||||||||
| 100 W BROADWAY SUITE 3000 | LONG BEACH | CA | 90802 | 2021-12-23 | $200,000 | TO DEVELOP AND TEST A TABLET-BASED APPLICATION THAT TRANSLATES DATA PULLED FROM A BABY'S ELECTRONIC MEDICAL RECORD INTO EASILY UNDERSTOOD, SIMPLE SENTENCES COMPLEMENTED BY VISUAL AIDS, SUCH AS GRAPHS AND CHARTS, FOR THE BENEFIT OF THE PUBLIC, INCLUDING PARENTS, IN AN ATTEMPT TO CHANGE THE STANDARD OF CARE BY IMPROVING LIVES, REDUCING MEDICAL ERRORS, AND REDUCING OVERALL HEALTHCARE COSTS. | $200,000 | NONE, SEE BELOW | PRI REPORT - 7/26/2023, 4/10/2024, 6/17/2024 | 2024-06-17 | THE TRUSTEES MEET WITH NICOLETTE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| NONINVASIX INC | |||||||||||||||||
| 1700 THE STRAND SUITE 1200 | GALVESTON | TX | 77555 | 2017-07-27 | $7,000 | TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. | $7,000 | NONE, SEE BELOW | PRI REPORTS - 1/27/2023, 4/27/2023, 5/25/2023, 8/3/2023, 11/08/2023, 5/31/20 | 2017-12-15 | THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| NONINVASIX INC | |||||||||||||||||
| 1700 THE STRAND SUITE 1200 | GALVESTON | TX | 77555 | 2015-12-30 | $150,000 | TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. | $150,000 | NONE, SEE BELOW | PRI REPORTS - 1/27/2023, 4/27/2023, 5/25/2023, 8/3/2023, 11/08/2023, 5/31/20 | 2017-12-15 | THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| NONINVASIXINC | |||||||||||||||||
| 1700 THE STRAND SUITE 1200 | GALVESTON | TX | 77555 | 2016-07-27 | $150,000 | TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. | $150,000 | NONE, SEE BELOW | PRI REPORTS - 1/27/2023, 4/27/2023, 5/25/2023, 8/3/2023, 11/08/2023, 5/31/20 | 2017-12-15 | THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| NOVONATE INC | |||||||||||||||||
| 395 OYSTER POINT BLVD SUITE 501 | SOUTH SAN FRANCISCO | CA | 94080 | 2022-08-03 | $150,000 | TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO BENEFIT THE PUBLIC BY DEVELOPING MEDICAL DEVICES FOR PATIENTS IN THE NEONATAL INTENSIVE CARE UNIT. | $150,000 | NONE, SEE BELOW | PRI REPORTS - 7/25/2023, 7/27/2023 | 2023-07-27 | NOVONATE WAS ACQUIRED IN 2023 AND THE $150,000 WAS REPAID TO THE FOUNDATION. PRIOR TO THIS, THE TRUSTEES MET WITH NOVONATE, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEWED THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| NURTURE GENOMICS | |||||||||||||||||
| CAMBRIDGE INNOVATION CENTER ONE | CAMBRIDGE | MA | 02142 | 2023-12-26 | $250,000 | TO SUPPORT THE PRE-COMMERCIAL AND PILOT DEVELOPMENT OF A SCREENING AND TELEHEALTH PLATFORM TO PROVIDE GENETIC INSIGHTS THAT HELP PARENTS AND THEIR MEDICAL PROVIDERS BETTER UNDERSTAND RISKS FROM CHILDBIRTH INTO ADOLESCENCE. | $11,974 | NONE, SEE BELOW | PRI REPORT - 6/23/2024 | 2024-06-23 | THE TRUSTEES MEET WITH NURTURE GENOMICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | BROADWAY KENDALL SQUARE | |||||
| PLAKOUS THERAPEUTICS | |||||||||||||||||
| 755 HIGHLAND OAKS DR SUITE 103 | WINSTONSALEM | NC | 27103 | 2023-07-03 | $250,000 | TO SUPPORT THE PRECLINICAL DEVELOPMENT OF A BIOLOGIC TO TREAT BABIES DIAGNOSED OR AT RISK OF DEVELOPING NECROTIZING ENTEROCOLITIS (NEC). | $250,000 | NONE, SEE BELOW | PRI REPORTS - 8/10/2023, 2/2/2024, 6/6/2024 | 2024-02-02 | THE TRUSTEES MEET WITH PLAKOUS THERAPEUTICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| PRAPELA LLC | |||||||||||||||||
| 2 MAIN STREET | BIDDEFORD | ME | 04005 | 2018-07-02 | $250,000 | TO SUPPORT THE DEVELOPMENT OF THE COMPANY'S SLEEP TECHNOLOGY PRODUCTS FOR IMPROVING THE HEALTH OF INFANTS WHO COULD BENEFIT FROM WITHDRAWAL TREATMENT AND POST-WITHDRAWAL SUPPORT OF NEONATAL ABSTINENCE SYNDROME ("NAS") A CONDITION CAUSED BY THE PRENATAL USE OF OPIOIDS OR OTHER DRUGS BY PREGNANT WOMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE, LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. | $250,000 | NONE, SEE BELOW | PRI REPORTS - 3/1/2023, 6/22/2023, 7/10/2023, 9/1/2023, 11/1/2023, 6/17/2024 | 2020-09-10 | THE TRUSTEES MEET WITH PRAPELA, LLC MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. | ||||||
| PRAPELA LLC | |||||||||||||||||
| 2 MAIN STREET | BIDDEFORD | ME | 04005 | 2023-12-20 | $50,000 | TO SUPPORT THE DEVELOPMENT OF THE COMPANY'S SLEEP TECHNOLOGY PRODUCTS FOR IMPROVING THE HEALTH OF INFANTS WHO COULD BENEFIT FROM WITHDRAWAL TREATMENT AND POST-WITHDRAWAL SUPPORT OF NEONATAL ABSTINENCE SYNDROME ("NAS") A CONDITION CAUSED BY THE PRENATAL USE OF OPIOIDS OR OTHER DRUGS BY PREGNANT WOMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE, LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. | $50,000 | NONE, SEE BELOW | PRI REPORTS - 3/1/2023, 6/22/2023, 7/10/2023, 9/1/2023, 11/1/2023, 6/17/2024 | 2024-09-24 | THE TRUSTEES MEET WITH PRAPELA, LLC MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. | ||||||
| SMOLTAP INC | |||||||||||||||||
| 150 CHESTNUT STREET SUITE C | PROVIDENCE | RI | 02903 | 2022-07-25 | $99,997 | TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO DEVELOP A NOVEL DEVICE WHICH HOLDS AN INFANT STABLE DURING THE LUMBER PUNCTURE PROCEDURE WHEN ADMINISTERING A SPINAL TAP TO DIAGNOSE MENINGITIS IN IN FEBRILE INFANTS UP TO FOUR WEEKS OLD. | $99,997 | NONE, SEE BELOW | PRI REPORTS - 2/15/2023, 5/30/2023, 12/22/2023, 5/30/2024, 9/3/2024 | 2023-05-30 | THE TRUSTEES MEET WITH SMOLTAP, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| SMOLTAP INC | |||||||||||||||||
| 150 CHESTNUT STREET SUITE C | PROVIDENCE | RI | 02903 | 2023-09-11 | $100,000 | TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO DEVELOP A NOVEL DEVICE WHICH HOLDS AN INFANT STABLE DURING THE LUMBER PUNCTURE PROCEDURE WHEN ADMINISTERING A SPINAL TAP TO DIAGNOSE MENINGITIS IN IN FEBRILE INFANTS UP TO FOUR WEEKS OLD. | $100,000 | NONE, SEE BELOW | PRI REPORTS - 2/15/2023, 5/30/2023, 12/22/2023, 5/30/2024, 9/3/2024 | 2024-05-30 | THE TRUSTEES MEET WITH SMOLTAP, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY | ||||||
| STINGRAY THERAPEUTICS | |||||||||||||||||
| 2450 HOLCOMBE BLVD SUITE X | HOUSTON | TX | 77021 | 2019-04-08 | $250,000 | FUNDS WILL BE USED FOR PRECLINICAL WORK FOCUSED ON PEDIATRIC BRAIN CANCERS, INCLUDING WORK TO DEVELOP PRECLINICAL MODELS AND TO TEST COMPOUNDS AGAINST MEDULLOBLASTOMA, AN ULTRA-RARE PEDIATRIC BRAIN CANCER, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE. | $250,000 | NONE, SEE BELOW | PRI REPORTS - 3/2/2023, 5/25/2023, 6/29/2023, 3/6/2024, 4/11/2024, 6/12/2024 | 2021-05-18 | THE TRUSTEES MEET WITH STINGRAY THERAPEUTICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. | ||||||
| THINKMD INC | |||||||||||||||||
| 166 MAIN STREET | BURLINGTON | VT | 05401 | 2018-05-17 | $150,000 | FOR DEVELOPING INTEGRATED CLINICAL ASSESSMENT AND DATA ANALYTICS PLATFORMS AND OTHER DERIVATIVE PRODUCTS THAT TRANSFORM POINT-OF-CARE MEDICINE BY PUTTING VALIDATED CLINICAL ASSESSMENT CAPABILITY AND INCREASED HEALTHCARE KNOWLEDGE INTO THE HANDS OF CLINICALLY UNTRAINED HEALTHCARE PROFESSIONALS AND FAMILIES THEREBY LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. | $150,000 | NONE, SEE BELOW | PRI REPORTS - 2/20/2023, 5/16/2023, 6/2/2023, 7/5/2023, 9/28/2023, 11/1/2023 | 2019-02-11 | THE TRUSTEES MEET WITH THINKMD, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. | ||||||
Investments Corp Bonds Schedule InvestmentsCorpBondsSchedule
Investments Corporate Bonds InvestmentsCorporateBondsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond | FIXED INCOME | BondNm |
| EOY Book Value | $13,614,650 | EOYBookValueAmt |
| EOYFMV | $13,614,650 | EOYFMVAmt |
Investments Corp Stock Schedule InvestmentsCorpStockSchedule
Investments Corporate Stock InvestmentsCorporateStockGrp (2 entries)
| StockStockNm | EOY Book ValueEOYBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|
| DOMESTIC EQUITIES | $25,644,572 | $25,644,572 |
| FOREIGN SECURITIES | $9,796,011 | $9,796,011 |
Investments Other Schedule2 InvestmentsOtherSchedule2
Investments Other InvestmentsOtherGrp (2 entries)
| Category Or ItemCategoryOrItemTxt | Listed At Cost Or FMVListedAtCostOrFMVCd | Book ValueBookValueAmt | EOYFMVEOYFMVAmt |
|---|---|---|---|
| REAL ESTATE | FMV | $4,763,054 | $4,763,054 |
| ALTERNATIVE INVESTMENTS | FMV | $13,979,158 | $13,979,158 |
Legal Fees Schedule LegalFeesSchedule
Legal Fees LegalFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Category | LEGAL EXPENSES | CategoryTxt |
| Legal Fees | $6,096 | LegalFeesAmt |
| Net Investment Income | $0 | NetInvestmentIncomeAmt |
| Disbursements Charitable Prps | $6,096 | DisbursementsCharitablePrpsAmt |
Other Assets Schedule OtherAssetsSchedule
Other Assets Schedule OtherAssetsScheduleGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | PROGRAM RELATED INVESTMENTS | Desc |
| BOY Book Value | $3,369,961 | BOYBookValueAmt |
| EOY Book Value | $4,006,057 | EOYBookValueAmt |
| EOYFMV | $4,006,057 | EOYFMVAmt |
Other Decreases Schedule OtherDecreasesSchedule
Other Decreases Detail OtherDecreasesDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | LOSS ON ALTERNATIVE INVESTMENTS | Desc |
| Amt | $609,912 | Amt |
Other Expenses Schedule OtherExpensesSchedule
Other Expenses Schedule OtherExpensesScheduleGrp (6 entries)
| DescDesc | Revenue And Expenses Per BooksRevenueAndExpensesPerBooksAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| MISCELLANEOUS EXPENSES | $5,795 | $0 | $5,795 |
| HRIA ADMINISTRATIVE COSTS | $256,489 | $0 | $256,489 |
| PROGRAM RELATED INVESTMENT ADMINISTRATIVE COSTS | $24,633 | $0 | $24,633 |
| MARKETING | $19,386 | $0 | $19,386 |
| HONORARIA | $18,650 | $0 | $18,650 |
| EVENT EXPENSE | $7,881 | $0 | $7,881 |
Other Income Schedule2 OtherIncomeSchedule2
Other Income Detail OtherIncomeDetail (2 entries)
| DescDesc | Revenue And Expenses Per BooksRevenueAndExpensesPerBooksAmt | Adjusted Net IncomeAdjustedNetIncomeAmt |
|---|---|---|
| RETURNED GRANT FUNDS | $6,033 | $6,033 |
| OTHER INVESTMENT INCOME | $567 | $567 |
Other Increases Schedule OtherIncreasesSchedule
Other Increases Detail OtherIncreasesDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | UNREALIZED GAIN | Desc |
| Amt | $5,298,086 | Amt |
Other Professional Fees Schedule OtherProfessionalFeesSchedule
Other Professional Fees Detail OtherProfessionalFeesDetail (2 entries)
| CategoryCategoryTxt | AmtAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| INVESTMENT FEES - US TRUST | $26,646 | $13,323 | $13,323 |
| INVESTMENT CONSULTING | $75,000 | $75,000 | $0 |
Taxes Schedule TaxesSchedule
Taxes Detail TaxesDetail (3 entries)
| CategoryCategoryTxt | AmtAmt | Net Investment IncomeNetInvestmentIncomeAmt | Disbursements Charitable PrpsDisbursementsCharitablePrpsAmt |
|---|---|---|---|
| FEDERAL EXCISE TAXES FOR 2023 | $20,000 | $0 | $0 |
| MA FORM PC FILING FEE | $1,039 | $0 | $1,039 |
| FOREIGN TAXES | $35,359 | $35,359 | $0 |
Comments